Babar Ghias
Förmögenhet: 3 M $ per 2026-06-30
Förmögenhet: 3 M $ per 2026-06-30
Babar Ghias is currently President & Director at Astria Therapeutics, Inc. since 2026.
Mr. Ghias is Chief Financial Officer at BioCryst Pharmaceuticals, Inc. since 2025.
Mr. Ghias is Chief Operating Officer at Castle Creek Biosciences, Inc. Former positions include Director at MyoTherix, Inc., Chief Financial Officer at AvenCell Therapeutics, Inc., and Vice President-Corporate Development at Marathon Pharmaceuticals LLC.
Education includes an undergraduate degree from Lahore University of Management Sciences and an MBA from Washington University in St. Louis.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-17 | 268 700 ( 0,11 % ) | 3 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2025-07-07 |
| ASTRIA THERAPEUTICS, INC. | President | 2026-01-23 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Verksamhetschef | - |
| Företag | Position | Slut |
|---|---|---|
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Direktör/Styrelseledamot | - |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Finansdirektör/CFO | - |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Washington University in St. Louis
Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astria Therapeutics, Inc.
Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Lahore University of Management Sciences
Lahore University of Management Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MyoTherix, Inc.
MyoTherix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focuses on the development of therapies | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
AvenCell Therapeutics, Inc.
AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for treatment of cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån